Lan YE, Zongyou WEI, Huan QU, Wenbin BAO, Shenglong WU

Polymorphisms of exon 10 in the BPI gene and its association analysis with some reproductive traits and partial immune indexes in Meishan pigs

This study was conducted to detect polymorphisms of BPI gene exon 10 by PCR-RFLP in Meishan pigs and their associationswith some important cytokine levels (IL-1β, IL-4, IL-6, IL-8, IL-10, TGF-1β, IFN-γ, TNF-α) and reproductive traits (total number born(TNB), number born alive (NBA), birth litter weight (BLW), and weaning litter weight (WLW)), with the aim of identifying effectivegenetic markers for molecular breeding. The results revealed three genotypes, including AA, AB, and BB, with the trend of AA > BB >AB in reproductive traits. Pigs with the AA genotype were significantly higher than the AB genotype in TNB and IFN-γ (P < 0.05), andextremely significantly higher in NBA and WLW (P < 0.01). Moreover, TGF-1β and TNF-α levels were significantly higher in the AAgenotype than the BB genotype (P < 0.05). However, there were no significant differences among the three genotypes in the levels ofother cytokines (P > 0.05). Comprehensive analysis indicated that the polymorphisms of exon 10 in the BPI gene have significant geneticeffects on some reproductive traits and cytokines in Meishan pigs, for which the AA genotype was demonstrated to be the favorablegenotype, which could be used as potential genetic markers for in-depth research and examination.

PDF

___

1. Weiss J, Elsbach P, Olsson I, Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978; 253: 2664-2672.
2. Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW. Bactericidal/permeability-increasing protein has endotoxinneutralizing activity. J Immunol 1990; 144: 662-666.
3. Iovine NM, Elsbach P, Weiss J. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. P Natl Acad Sci USA 1997; 94: 10973-10978.
4. Wilde CG, Seilhamer JJ, McGrogan M, Ashton N, Snable JL, Lane JC, Leong SR, Thornton MB, Miller KL, Scott RW, et al. Bactericidal/ permeability-increasing protein and lipopolysaccharide (LPS)- binding protein. LPS binding properties and effects on LPSmediated cell activation. J Biol Chem 1994; 269: 17411-17416.
5. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 1998; 64: 14-18.
6. Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Schmiegel W, Griga T. A polymorphism of the bactericidal/ permeability increasing protein (BPI) gene is associated with Crohn’s disease. J Clin Gastroenterol 2005; 39: 282-283.
7. Jagiello P, Klein W, Schultz H, Csernok E, Gross WL, Epplen JT. Association study of Wegener granulomatosis and the functionally relevant A645G polymorphism in the bactericidal/ permeability increasing protein (BPI) gene. Int J Immunogenet 2005; 32: 3-6.
8. van der Schaft DW, Toebes EA, Haseman JR, Mayo KH, Griffioen AW. Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood 2000; 96: 176-181.
9. Schultz H, Weiss JP. The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta 2007; 384: 12-23.
10. Zhou H, Zheng J, Qin X, Xiao G. Enhancement of anti-human bactericidal/permeability increasing protein (BPI) antibodies on bio-activities of porcine bpi in vitro. Acta Academiae Medicine Militaris Tertiae 2002; 24: 76-78.
11. Shi XW, Mellencamp MA, Stabel TJ, Galina-pantoja L, Batiaansen J, Tuggle CK. Complete cDNA cloning and polymorphisms at porcine BPI: associations with bacterial load and immune response traits in pigs. In: Plant and Animal Genome Conference Proceedings; 2003. p. 231.
12. Tuggle CK, Thomas JS, Shi XW, Mellencamp MA. Genetic Markers for Improved Disease Resistance in Animals (BPI). United States Patent Application Publication No. 7070929 B2, 2006.
13. Wittmann I, Schönefeld M, Aichele D, Groer G, Gessner A, Schnare M. Murine bactericidal/permeability-increasing protein inhibits the endotoxic activity of lipopolysaccharide and gramnegative bacteria. J Immunol 2008; 180: 7546-7552.
14. Holweg A, Schnare M, Gessner A. The bactericidal/permeabilityincreasing protein (BPI) in the innate defence of the lower airways. Biochem Soc T 2011; 39: 1045-1050.
15. Wu ZC, Liu Y, Zhao QH, Zhu SP, Huo YJ, Zhu GQ, Wu SL, Bao WB. Association between polymorphisms in exons 4 and 10 of the BPI gene and immune indices in Sutai pigs. Genet Mol Res 2015; 14: 6048-6058.
16. Liu L, Wang J, Zhao QH, Zi C, Wu ZC, Su XM, Huo YJ, Zhu GQ, Wu SL, Bao WB. Genetic variation in exon 10 of the BPI gene is associated with Escherichia coli F18 susceptibility in Sutai piglets. Gene 2013; 523: 70-75.
17. Ye L, Zi C, Liu L, Zhu J, Xie KZ, Zhu GQ, Huang XG, Bao WB, Wu SL, Wang JY. Study on the relationship between the expression of BPI gene and Escherichia coli F18 infection in piglets. Yi Chuan 2011; 33: 1225-1230 (in Chinese with an abstract in English).
18. Zhu J. Effect of BPI gene involved in resistance to E. coli F18 infection of weaning piglets. PhD, Yangzhou University, Jiangsu, China, 2012 (in Chinese with an English abstract)
19. Miguel MA, Mingala CN. Screening of pig (Sus scrofa) bactericidal permeability-increasing protein (BPI) gene as marker for disease resistance. Anim Biotechnol 2018; 5: 1-5.
20. Prud’homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-β1) in autoimmune diseases. J Autoimmun 2000; 14: 23-42.
21. Hunziker EB, Rosenberg LC. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am 1996; 78: 721-733.
22. Troncone E, Marafini I, Stolfi C, Monteleone G. Transforming growth factor-β1/Smad7 in intestinal immunity, inflammation, and cancer. Front Immuno 2018; 9: 1407.
23. Schioppa T, Moore R, Thompson RG, Rosser EC, Kulbe H, Nedospasov S. B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis. P Natl Acad Sci USA 2011; 108: 10662-10667.
24. Zganiacz A, Santosuosso M, Wang J, Yang, T, Chen, L, Anzulovic M. TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 2004; 113: 401.
25. Shime H, Maruyama A, Yoshida S, Takeda Y, Matsumoto M, Seya T. Toll-like receptor 2 ligand and interferon-γ suppress antitumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells. Oncoimmunology 2018; 7: e1373231.
26. Zhang X, Zeng Y, Qu Q, Zhu J, Liu Z, Ning W. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer. Int J Clin Oncol 2017; 26: 1026-1033.
27. Rowland RRR, Robinson B, Stefanick J, Kim TS, Guanghua L, Lawson SR, Benfield DA. Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with 2-aminopurine. Arch Virol 2001; 146: 539-555.
28. Li LF, Yu J, Zhang Y, Yang Q, Li Y, Zhang L. Interferon-inducible oligoadenylate synthetase-like protein acts as an antiviral effector against classical swine fever virus via the MDA5-mediated type I interferon signaling pathway. J Virol 2017; 91: e01514.